Literature DB >> 32282650

Primary Renal Ewing Sarcoma in Children and Young Adults.

Kathryn Bradford1, Alexander Nobori2, Brittany Johnson3, Wendy Allen-Rhoades4, Bindi Naik-Mathuria3, Eduard H Panosyan5, Moran Gotesman5, Joseph Lasky5,6, Jerry Cheng7, Alan Ikeda6, Jeffrey Goldstein2, Arun Singh8, Noah Federman1.   

Abstract

The Ewing sarcoma family of tumors (ESFT) are high-grade small round blue cell malignancies traditionally presenting in children and adolescents. The most common site of primary disease is bone, though extraskeletal primary sites are well-recognized. We present 6 cases of primary ESFT of the kidney and 1 case of the adrenal gland. Patients were 11 to 18 years of age at diagnosis. Metastases at diagnosis were present in most cases (n=6). All patients underwent surgery, and most received radiation (n=5). Five patients relapsed after initial remission. Comprehensive review of the primary renal ESFT literature was used to analyze various factors, including age, sex, disease metrics, metastases at diagnoses, and overall survival in a total of 362 cases. Notably, while the general ESFT population has reported rates of metastasis at diagnosis of 20% to 25%, this rate in the renal ESFT population was 53% with a rate of 59% in adolescent and young-adult patients (11 to 24 y). Nodal disease at diagnosis was present in 24% of renal ESFT cases compared with 3.2% in patients with primary skeletal ESFT. While this malignant process may share histologic and molecular features with its bone and soft tissue counterparts, primary renal ESFT presentations seem to be more aggressive and have worse outcomes.

Entities:  

Mesh:

Year:  2020        PMID: 32282650      PMCID: PMC7554078          DOI: 10.1097/MPH.0000000000001804

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.170


  23 in total

1.  Lymphoma of the kidney: primary or initial manifestation of rapidly progressive systemic disease?

Authors:  Ahmet Tefekli; Murat Baykal; Murat Binbay; Mustafa Barut; Ahmet Yaser Muslumanoglu
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

2.  Desmoplastic Small Round Cell Tumor of the Kidney: AIRP Best Cases in Radiologic-Pathologic Correlation.

Authors:  William J Walton; Raina R Flores
Journal:  Radiographics       Date:  2016 Sep-Oct       Impact factor: 5.333

3.  Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement.

Authors:  Mark A Applebaum; Robert Goldsby; John Neuhaus; Steven G DuBois
Journal:  Pediatr Blood Cancer       Date:  2011-12-19       Impact factor: 3.167

4.  Ewing's sarcoma of the kidney.

Authors:  Joel R Angel; Anushayanthan Alfred; Ankit Sakhuja; Ryan E Sells; Joseph John Zechlinski
Journal:  Int J Clin Oncol       Date:  2010-03-04       Impact factor: 3.402

5.  Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.

Authors:  Richard B Womer; Daniel C West; Mark D Krailo; Paul S Dickman; Bruce R Pawel; Holcombe E Grier; Karen Marcus; Scott Sailer; John H Healey; John P Dormans; Aaron R Weiss
Journal:  J Clin Oncol       Date:  2012-10-22       Impact factor: 44.544

6.  Primary Renal Rhabdomyosarcoma: An Unusual Bone Metastasizing Tumor of Kidney.

Authors:  Shabnam Parvin; Ranajoy Ghosh; Ram Narayan Das; Koushik Saha; Paromita Roy; Chhanda Datta; Uttara Chatterjee
Journal:  Fetal Pediatr Pathol       Date:  2016-05-16       Impact factor: 0.958

7.  Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement.

Authors:  Dina El Demellawy; Caitlin A Cundiff; Ahmed Nasr; John A Ozolek; Nancy Elawabdeh; Shelley A Caltharp; Pourya Masoudian; Katrina J Sullivan; Joseph de Nanassy; Bahig M Shehata
Journal:  Pathology       Date:  2015-12-18       Impact factor: 5.306

8.  Renal Lymphoma: Primary or First Manifestation of Aggressive Pediatric B-cell Lymphoma.

Authors:  Pragnya Coca; Vijay Gandhi Linga; Sadashivudu Gundeti; Ashwani Tandon
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Oct-Dec

9.  High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008.

Authors:  Jeremy Whelan; Marie-Cecile Le Deley; Uta Dirksen; Gwénaël Le Teuff; Bernadette Brennan; Nathalie Gaspar; Douglas S Hawkins; Susanne Amler; Sebastian Bauer; Stefan Bielack; Jean-Yves Blay; Stefan Burdach; Marie-Pierre Castex; Dagmar Dilloo; Angelika Eggert; Hans Gelderblom; Jean-Claude Gentet; Wolfgang Hartmann; Wolf-Achim Hassenpflug; Lars Hjorth; Marta Jimenez; Thomas Klingebiel; Udo Kontny; Jarmila Kruseova; Ruth Ladenstein; Valerie Laurence; Cyril Lervat; Perrine Marec-Berard; Sandrine Marreaud; Jean Michon; Bruce Morland; Michael Paulussen; Andreas Ranft; Peter Reichardt; Hendrik van den Berg; Keith Wheatley; Ian Judson; Ian Lewis; Alan Craft; Heribert Juergens; Odile Oberlin
Journal:  J Clin Oncol       Date:  2018-09-06       Impact factor: 44.544

10.  High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.

Authors:  Uta Dirksen; Bernadette Brennan; Marie-Cécile Le Deley; Nathalie Cozic; Henk van den Berg; Vivek Bhadri; Bénédicte Brichard; Line Claude; Alan Craft; Susanne Amler; Natalie Gaspar; Hans Gelderblom; Robert Goldsby; Richard Gorlick; Holcombe E Grier; Jean-Marc Guinbretiere; Peter Hauser; Lars Hjorth; Katherine Janeway; Heribert Juergens; Ian Judson; Mark Krailo; Jarmila Kruseova; Thomas Kuehne; Ruth Ladenstein; Cyril Lervat; Stephen L Lessnick; Ian Lewis; Claude Linassier; Perrine Marec-Berard; Neyssa Marina; Bruce Morland; Hélène Pacquement; Michael Paulussen; R Lor Randall; Andreas Ranft; Gwénaël Le Teuff; Keith Wheatley; Jeremy Whelan; Richard Womer; Odile Oberlin; Douglas S Hawkins
Journal:  J Clin Oncol       Date:  2019-09-25       Impact factor: 50.717

View more
  2 in total

1.  Effective natural inhibitors targeting IGF-1R by computational study.

Authors:  Xinyu Wang; Pengcheng Zhou; Liangxin Lin; Bo Wu; Zhaoyu Fu; Xing Huang; Dong Zhu
Journal:  Aging (Albany NY)       Date:  2022-06-09       Impact factor: 5.955

2.  Primary Adult Renal Ewing's Sarcoma: A Rare Entity.

Authors:  Darilin M Shangpliang; Gordon Rangad; Jayanta Kumar Das; Kirtijit Chakma
Journal:  Cureus       Date:  2022-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.